IXJ: Healthcare Sector Dashboard For September

Healthcare equipment is undervalued based on historical averages, while other subsectors are slightly overvalued. The iShares Global Healthcare ETF offers diversified global healthcare exposure, with 72% in US companies and 110 holdings. Despite lower company-specific risk and better value, IXJ has underperformed XLV by about 2% annualized over both long and short timeframes.

Seeking Alpha • Sep 17, 2026

Does Fidelity or iShares Have the Better Healthcare ETF For Investors Seeking Broad Exposure?

Fidelity MSCI Health Care Index ETF has a significantly lower expense ratio than iShares Global Healthcare ETF. iShares Global Healthcare ETF provides exposure to international healthcare markets, whereas the Fidelity fund focuses on U.S. equities.

The Motley Fool • Sep 16, 2026

State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors

XLV has a significantly lower expense ratio of 0.08% compared to IXJ's 0.38%. IXJ provides broader exposure with 110 holdings across global markets, while XLV concentrates on 60 domestic S&P 500 stocks.

The Motley Fool • Sep 13, 2026

IXJ vs XPH: Global Healthcare ETF or Pharma Focus?

iShares Global Healthcare ETF provides broad sector coverage with a higher dividend yield than State Street SPDR S&P Pharmaceuticals ETF. State Street SPDR S&P Pharmaceuticals ETF has delivered stronger total returns over the last year but experiences significantly higher maximum drawdowns.

The Motley Fool • Sep 12, 2026

FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now

FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market and four healthcare ETFs to watch.

Zacks Investment Research • Aug 27, 2026

Which Healthcare ETF Is the Better Buy: Vanguard's VHT or iShares' IXJ?

The Vanguard Health Care ETF (VHT) is significantly cheaper to own than the iShares Global Healthcare ETF (IXJ). IXJ offers exposure to international companies, while VHT focuses more heavily on the U.S. market.

The Motley Fool • Aug 25, 2026

iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond?

iShares Global Healthcare ETF offers a 1.4% dividend yield and lower price volatility than State Street SPDR S&P Biotech ETF. State Street SPDR S&P Biotech ETF focuses on U.S. biotechnology, resulting in a higher 1-year total return of 80.2% but a significantly deeper maximum drawdown.

The Motley Fool • Aug 8, 2026

iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026?

iShares Global Healthcare ETF provides broader diversification with 110 holdings compared to 25 positions in VanEck Biotech ETF VanEck Biotech ETF delivered a 30.8% 1-year total return but has experienced a 39.9% historical maximum drawdown iShares Global Healthcare ETF offers a 1.5% trailing-12-month dividend yield and a longer history since its 2001 launch

The Motley Fool • Jul 23, 2026

Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB?

iShares Global Healthcare ETF provides lower-cost exposure to the broader medical sector than iShares Biotechnology ETF. iShares Biotechnology ETF has delivered higher 1-year total returns but with significantly greater price volatility.

The Motley Fool • Jul 23, 2026

PINK vs. IXJ: Which Health Care ETF Is the Better Buy for Investors?

The iShares Global Healthcare ETF (IXJ) charges a lower expense ratio and pays a higher dividend yield than the Simplify Health Care ETF (PINK). PINK has delivered stronger one-year and three-year returns than IXJ.

The Motley Fool • Jul 22, 2026